NCT04380727View on ClinicalTrials.gov

Almitrine and COVID-19 Related Hypoxemia

CompletedOBSERVATIONAL
Enrollment

17

Participants

Timeline

Start Date

March 20, 2020

Primary Completion Date

April 14, 2020

Study Completion Date

April 25, 2020

Conditions
COVID-19Hypoxic Respiratory Failure
Trial Locations (1)

54511

Centre Hospitalier Universitaire NANCY, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT04380727 - Almitrine and COVID-19 Related Hypoxemia | Biotech Hunter | Biotech Hunter